Asian Pacific Journal of Cancer Prevention

  • 제13권5호
  • /
  • Pages.1761-1766
  • /
  • 2012
  • /
  • 1513-7368(pISSN)
  • /
  • 2476-762X(eISSN)
아시아태평양암예방학회 (Asian Pacific Journal of Cancer Prevention)
권호 표지
DOI QR코드

DOI QR Code

Repeat Colonoscopy Every 10 Years or Single Colonoscopy for Colorectal Neoplasm Screening in Average-risk Chinese: A Cost-effectiveness Analysis

  • Wang, Zhen-Hua (Division of Gastroenterology and Hepatology, Shanghai Jiao-Tong University School of Medicine Renji Hospital) ;
  • Gao, Qin-Yan (Division of Gastroenterology and Hepatology, Shanghai Jiao-Tong University School of Medicine Renji Hospital) ;
  • Fang, Jing-Yuan (Division of Gastroenterology and Hepatology, Shanghai Jiao-Tong University School of Medicine Renji Hospital)
  • 발행 : 2012.05.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Background: The appropriate interval between negative colonoscopy screenings is uncertain, but the numbers of advanced neoplasms 10 years after a negative result are generally low. We aimed to evaluate the cost-effectiveness of colorectal neoplasm screening and management based on repeat screening colonoscopy every 10 years or single colonoscopy, compared with no screening in the general population. Methods and materials: A state-transition Markov model simulated 100,000 individuals aged 50-80 years accepting repeat screening colonoscopy every 10 years or single colonoscopy, offered to every subject. Colorectal adenomas found during colonoscopy were removed by polypectomy, and the subjects were followed with surveillance every three years. For subjects with a normal result, colonoscopy was resumed within ten years in the repeat screening strategy. In single screening strategy, screening process was terminated. Direct costs such as screening tests, cancer treatment and costs of complications were included. Indirect costs were excluded from the model. The incremental cost-effectiveness ratio was used to evaluate the cost-effectiveness of the different screening strategies. Results: Assuming a first-time compliance rate of 90%, repeat screening colonoscopy and single colonoscopy can reduce the incidence of colorectal cancer by 65.8% and 67.2% respectively. The incremental cost-effectiveness ratio for single colonoscopy (49 Renminbi Yuan [RMB]) was much lower than that for repeat screening colonoscopy (474 RMB). Single colonoscopy was a more cost-effective strategy, which was not sensitive to the compliance rate of colonoscopy and the cost of advanced colorectal cancer. Conclusion: Single colonoscopy is suggested to be the more cost-effective strategy for screening and management of colorectal neoplasms and may be recommended in China clinical practice.

키워드

참고문헌

  1. Atkin W, MOrosn B, Cuzick J (1992). Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Eng J Med, 326, 658-62. https://doi.org/10.1056/NEJM199203053261002
  2. Brenner H, Haug U, Arndt V, et al (2010). Low risk of colorectal cancer and advanced adenomas more than 10 years after negative colonoscopy. Gastroenterology, 138, 870-6. https://doi.org/10.1053/j.gastro.2009.10.054
  3. Chen CD, Yen MF, Wang WM, et al (2003). A case-cohort study for the disease natural history of adenoma-carcinoma and de novo carcinoma and surveillance of colon and rectum after polypectomy: implication for efficacy of colonoscopy. Br J Cancer, 88, 1866-73. https://doi.org/10.1038/sj.bjc.6601007
  4. Drummond MF, Jefferson TO (1996). Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ, 313, 275-83. https://doi.org/10.1136/bmj.313.7052.275
  5. Hankey BF, Ries LA, Kosary CL, et al (2000). Partitioning linear trends in age-adjusted rates. Cancer Causes Control, 11, 31-5. https://doi.org/10.1023/A:1008953201688
  6. Hardcastle JD, Chamberlain JO, Robinson MH, et al (1996). Randomised controlled trial of faecal-occultblood screening for colorectal cancer. Lancet, 348, 1472-7. https://doi.org/10.1016/S0140-6736(96)03386-7
  7. Hou SI, Chen PH (2004). Home-administered fecal occult blood test for colorectal cancer screening among worksites in Taiwan. Prev Med, 38, 78-84.
  8. Huang Y, Gong W, Su B, Zhi F, et al (2010). Recurrence and surveillance of colorectal adenoma after polypectomy in a southern Chinese population. J Gastroenterol, 45, 838-45. https://doi.org/10.1007/s00535-010-0227-3
  9. Hui AJ, Wong RM, Ching JY, et al (2004). Risk of colonoscopic polypectomy bleeding with anticoagulants and antiplatelet agents: analysis of 1657 cases. Gastrointest Endosc, 59, 44-8. https://doi.org/10.1016/S0016-5107(03)02307-1
  10. Imperiale TF, Glowinski EA, Lin-Cooper C, et al (2008). Fiveyear risk of colorectal neoplasia after negative screening colonoscopy. N Engl J Med, 359, 1218-24. https://doi.org/10.1056/NEJMoa0803597
  11. Kronborg O, Fenger C, Olsen J, et al (1996). Randomised study of screening for colorectal cancer with faecaloccult- blood test. Lancet, 348, 1467-71. https://doi.org/10.1016/S0140-6736(96)03430-7
  12. Leung WK, Lau JY, Suen BY, et al (2009). Repeat-screening colonoscopy 5 years after normal baseline-screening colonoscopy in average-risk Chinese: a prospective study. Am J Gastroenterol, 104, 2028-34. https://doi.org/10.1038/ajg.2009.202
  13. Levin B, Lieberman DA, McFarland B, et al (2008). A Joint Guideline from the American Cancer Society, the US Multi- Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology, 134, 1570-95. https://doi.org/10.1053/j.gastro.2008.02.002
  14. Lieberman DA, Weiss DG, Bond JH, et al (2000). Use of colonoscopy to screen asymptomatic adults for colorectal cancer. N Engl J Med, 343, 162-8. https://doi.org/10.1056/NEJM200007203430301
  15. Li S, Nie Z, Li N, et al (2003). Colorectal cancer screening for the natural population of Beijing with sequential fecal occult blood test: a multicenter study. Chin Med J, 116, 200-2.
  16. Liu HH, Wu MC, Peng Y, et al (2005). Prevalence of advanced colonic polyps in asymptomatic Chinese. World J Gastroenterol, 11, 4731-4. https://doi.org/10.3748/wjg.v11.i30.4731
  17. Lu JB, Sun XB, Dai DX, et al (2003). Epidemiology of gastroenterologic cancer in Henan Province, China. World J Gastroenterol, 9, 2400-3. https://doi.org/10.3748/wjg.v9.i11.2400
  18. Mandel JS, Church TR, Bond JH, et al (2000). The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med, 343, 1603-7. https://doi.org/10.1056/NEJM200011303432203
  19. Martinez ME, Baron JA, Lieberman DA, et al (2009). A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology, 136, 832-41. https://doi.org/10.1053/j.gastro.2008.12.007
  20. Noshirwani KC, van Stolk RU, Rybicki LA, et al (2005). Adenoma size and number are predictive of adenoma recurrence: implications for surveillance colonoscopy. Gastrointest Endosc, 51, 433-7.
  21. Pariente A, Milan C, Lafon J, et al (1998). Colonoscopic screening in first-degree relatives of patients with 'sporadic' colorectal cancer: a case-control study. Gastroenterology, 115, 7-12. https://doi.org/10.1016/S0016-5085(98)70358-0
  22. Pignone M, Rich M, Teutsch SM, et al (2002). Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med, 137, 132-41. https://doi.org/10.7326/0003-4819-137-2-200207160-00015
  23. Rodriguez-Moranta F, Salo J, Arcusa A, et al (2006). Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial. J Clin Oncol, 24, 386-93. https://doi.org/10.1200/JCO.2005.02.0826
  24. Sonnenberg A, Delcò F (2002). Cost-effectiveness of a single colonoscopy in screening for colorectal cancer. Arch Intern Med, 162, 163-8. https://doi.org/10.1001/archinte.162.2.163
  25. Sung JJ, Lau JY, Young GP, et al (2008). Asia Pacific consensus recommendations for colorectal cancer screening. Gut, 57, 1166-76. https://doi.org/10.1136/gut.2007.146316
  26. VanStolk R, Beck G, Baron J, et al (1998). Adenoma characteristics at first colonoscopy as predictors of adenoma recurrence and characteristics at follow-up. Gastroenterology, 115, 13-8. https://doi.org/10.1016/S0016-5085(98)70359-2
  27. Winawer SJ , Zauber AG , Fletcher RH, et al (2006). Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology, 130, 1872-85. https://doi.org/10.1053/j.gastro.2006.03.012
  28. Winawer SJ, Zauber AG, Ho MN, et al (1993). Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med, 329, 1977-81. https://doi.org/10.1056/NEJM199312303292701
  29. Wu GH, Wang YM, Yen AM, et al (2006). Costeffectiveness analysis of CRC screening with stool DNA testing in intermediateincidence countries. BMC Cancer, 6, 136. https://doi.org/10.1186/1471-2407-6-136
  30. Xu AG, Jiang B, Yu ZJ, et al (2007). Epidemiology investigation of colorectal cancer on community group in Guangdong province. Zhonghua Yi Xue Za Zhi, 28, 1950-3.
  31. Yang KC, Liao CS, Chiu YH, et al (2006). Colorectal cancer screening with faecal occult blood test within a multiple disease screening programme: an experience from Keelung, Taiwan. J Med Screen, 13, S8-13. https://doi.org/10.1258/096914106776179782

피인용 문헌

  1. Colonoscopy in Colorectal Cancer Screening: Current Aspects vol.6, pp.3, 2015, https://doi.org/10.1007/s13193-015-0410-3
  2. Modeling and Control of Colorectal Cancer vol.11, pp.8, 2016, https://doi.org/10.1371/journal.pone.0161349